Assessment of renal and cardiovascular risks in patients with type 2 diabetes when using non-steroidal mineralocorticoid receptor antagonists

Background. Given the proven excessive activation of the renin-angiotensin-aldosterone system and the clinical manifestations of hypertension, mostly of renal origin, there is a need to optimize antihypertensive therapy aimed at an active nephroprotection. The purpose of the study is to carry out a...

Full description

Bibliographic Details

Published in:	Miz︠h︡narodnyĭ endokrynolohichnyĭ z︠h︡urnal Vol. 19; no. 8; pp. 579 - 585
Main Authors:	Yerokhovych, V.М., Komisarenko, Y.I., Karpenko, O.V., Pankiv, V.I., Kobyliak, N.M., Bobryk, M.I., Kyriienko, D.V., Gurska, K.S., Kaplina, A.A., Vasiuk, V.L.
Format:	Journal Article
Language:	English
Published:	Zaslavsky O.Yu 09-01-2024
Subjects:	chronic kidney disease diabetes mellitus hypertension mineralocorticoid receptor antagonists primary hyperaldosteronism
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!